Literature DB >> 11958869

In vivo metabolism and clearance of substance P and co-expressed tachykinins in rat striatum.

A T Michael-Titus1, K Fernandes, H Setty, R Whelpton.   

Abstract

Neurons expressing the preprotachykinin A gene, which encodes the sequences of substance P, neurokinin A, neuropeptide gamma and neuropeptide K, exemplify peptide co-existence. Furthermore, there is also evidence that substance P fragments have biological activity. However, the relative contribution of each of these peptides to tachykinin signalling is still poorly understood. An important factor which will determine the characteristics of the signal mediated by co-localised peptides is their clearance from the extracellular space. The striatum, in which tachykinins are present and exert neuromodulatory roles, can be used as a model to investigate this aspect. Therefore, in this study we characterised in vivo in the striatum the metabolism and clearance of substance P and of the other three co-expressed peptides. After intrastriatal administration of 1 pmol, tritiated substance P disappeared too rapidly for metabolites to be detected. However, when 10 nmol substance P and 1 pmol tritiated substance P were co-injected, substance P(1-4) and substance P(1-7), which are biologically active, were detected as major metabolites. Under these conditions, the rate of decay of tritiated substance P was 0.2 nmol/min. The effects of the peptidase inhibitors thiorphan, bestatin and captopril suggested that neutral endopeptidase 24.11 and aminopeptidases were involved in primary substance P cleavages, whereas angiotensin-converting enzyme was involved in secondary cleavages. The monitoring of the decay of unlabelled substance P by high-performance liquid chromatography gave a rate of 0.16 nmol/min. Using high-performance liquid chromatography with capillary electrophoresis, the rates of decay of 10 nmol neurokinin A or neuropeptide gamma were five and seven times faster than that of substance P. In contrast, over the time course of the experiment, no significant decay of neuropeptide K was detected. These results show that substance P disappears rapidly from the extracellular space, and supports the formation in vivo of major N-terminal active substance P metabolites. Our study also highlights significant differences in the clearance of co-expressed tachykinins and suggests that certain species may disappear relatively slowly from the extracellular space, and thus may make a significant temporal and spatial contribution to signalling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958869     DOI: 10.1016/s0306-4522(01)00530-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  12 in total

1.  Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS.

Authors:  Arvind K Chappa; Joshua D Cooper; Kenneth L Audus; Susan M Lunte
Journal:  J Pharm Biomed Anal       Date:  2006-11-21       Impact factor: 3.935

2.  The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.

Authors:  S V Nikolaev; A A Lebedev; E R Bychkov; A V Oblyapin; S A Dambinova; P D Shabanov
Journal:  Neurosci Behav Physiol       Date:  2004-09

3.  Human Opiorphin, a natural antinociceptive modulator of opioid-dependent pathways.

Authors:  Anne Wisner; Evelyne Dufour; Michaël Messaoudi; Amine Nejdi; Audrey Marcel; Marie-Noelle Ungeheuer; Catherine Rougeot
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

4.  Localization of substance P (SP)-immunoreactivity in the myenteric plexus of the rat esophagus.

Authors:  Ryo Morishita; Ryoichi Yoshimura; Hiroshi Sakamoto; Hirofumi Kuramoto
Journal:  Histochem Cell Biol       Date:  2022-05-04       Impact factor: 4.304

5.  Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity.

Authors:  Catherine Rougeot; Michaël Messaoudi; Véronique Hermitte; Anne Gaëlle Rigault; Thierry Blisnick; Christophe Dugave; Didier Desor; François Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

6.  Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid.

Authors:  B Reed; J M Bidlack; B T Chait; M J Kreek
Journal:  J Neuroendocrinol       Date:  2008-03-15       Impact factor: 3.627

7.  Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception.

Authors:  M V Hamity; S R White; D L Hammond
Journal:  Neuroscience       Date:  2009-11-03       Impact factor: 3.590

8.  Histological evidence supporting a role for the striatal neurokinin-1 receptor in methamphetamine-induced neurotoxicity in the mouse brain.

Authors:  Jing Yu; Jing Wang; Jean Lud Cadet; Jesus A Angulo
Journal:  Brain Res       Date:  2004-05-08       Impact factor: 3.252

9.  Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.

Authors:  Florence Noble; Nadia Benturquia; Andras Bilkei-Gorzo; Andreas Zimmer; Bernard P Roques
Journal:  Psychopharmacology (Berl)       Date:  2007-10-01       Impact factor: 4.530

10.  The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.

Authors:  Ashley J Porter; Katharine Pillidge; Ewelina M Grabowska; S Clare Stanford
Journal:  Eur Neuropsychopharmacol       Date:  2015-02-07       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.